← Back to headlines
FTC monitoring how Big Pharma reacts to upcoming patent cliffs, official says
An official from the Federal Trade Commission (FTC) stated that the agency is monitoring how major pharmaceutical companies are reacting to upcoming patent expirations.
18 Mar, 11:39 — 18 Mar, 11:39
Sources
Showing 1 of 1 sources
Related Stories
Volkswagen Proposes Closing Four German Plants by 2034 Amid Industry Shift
22m ago
IKEA Slashes Prices on Thousands of Products Across Europe
40m ago
Micron Workers in Taiwan Threaten Strike Over Bonus Disputes
42m ago
US Regulators and States Sue Amazon Over Alleged Digital Advertising Price Rigging
53m ago